Vertex Pharmaceuticals, Inc. (VRTX)
515.44
+0.88
(+0.17%)
USD |
NASDAQ |
Sep 11, 16:00
515.73
+0.29
(+0.06%)
After-Hours: 20:00
Vertex Pharmaceuticals Price : 515.44 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 522.10 | 522.10 | 511.81 | 515.44 | 875636.0 |
| Sep 10, 2026 | 519.13 | 522.60 | 514.32 | 514.56 | 815172.0 |
| Sep 09, 2026 | 524.00 | 528.16 | 520.08 | 521.12 | 958511.0 |
| Sep 08, 2026 | 529.64 | 535.00 | 520.20 | 528.90 | 1.121M |
| Sep 04, 2026 | 549.50 | 556.99 | 544.48 | 546.12 | 803524.0 |
| Sep 03, 2026 | 559.00 | 560.25 | 551.61 | 557.96 | 800964.0 |
| Sep 02, 2026 | 552.42 | 558.36 | 549.07 | 556.75 | 1.735M |
| Sep 01, 2026 | 548.60 | 551.40 | 545.08 | 547.65 | 735119.0 |
| Aug 31, 2026 | 535.38 | 546.84 | 532.23 | 544.52 | 1.198M |
| Aug 28, 2026 | 547.09 | 549.57 | 540.08 | 541.69 | 886917.0 |
| Aug 27, 2026 | 540.08 | 550.83 | 540.08 | 547.55 | 844619.0 |
| Aug 26, 2026 | 549.84 | 553.47 | 546.24 | 547.29 | 834375.0 |
| Aug 25, 2026 | 545.53 | 555.69 | 543.75 | 552.85 | 775040.0 |
| Aug 24, 2026 | 548.98 | 550.62 | 542.42 | 547.59 | 767491.0 |
| Aug 21, 2026 | 545.10 | 555.32 | 540.70 | 548.05 | 1.075M |
| Aug 20, 2026 | 543.78 | 548.98 | 538.27 | 540.26 | 1.062M |
| Aug 19, 2026 | 537.47 | 553.69 | 532.55 | 552.06 | 1.438M |
| Aug 18, 2026 | 520.00 | 533.78 | 517.34 | 528.19 | 1.497M |
| Aug 17, 2026 | 503.87 | 517.84 | 502.53 | 515.55 | 1.111M |
| Aug 14, 2026 | 511.41 | 513.64 | 502.29 | 505.75 | 1.131M |
| Aug 13, 2026 | 528.68 | 529.00 | 515.74 | 516.44 | 863530.0 |
| Aug 12, 2026 | 527.00 | 531.22 | 520.08 | 525.73 | 1.047M |
| Aug 11, 2026 | 525.02 | 532.23 | 522.01 | 529.65 | 1.065M |
| Aug 10, 2026 | 539.50 | 546.17 | 519.82 | 523.91 | 2.682M |
| Aug 07, 2026 | 487.11 | 497.40 | 482.10 | 496.07 | 992491.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 143.72 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Sionna Therapeutics, Inc. | 7.85 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
| Biogen, Inc. | 217.15 |
Price Related Metrics
| PE Ratio | 29.99 |
| PS Ratio | 10.40 |
| PEG Ratio | 1.312 |
| Price to Book Value | 6.449 |
| Price to Free Cash Flow | 34.80 |
| Earnings Yield | 3.33% |
| Market Cap | 130.59B |
| PEGY Ratio | 1.312 |
| Operating PE Ratio | 26.31 |
| Normalized PE Ratio | 29.19 |